Why Innovation Centers Matter To Global Healthcare

The biggest advantage India offers today is the breadth of its ecosystem. Healthcare companies can draw on capabilities that extend well beyond healthcare itself. The automobile industry has helped develop a mature supplier and manufacturing ecosystem, while consumer electronics has strengthened expertise in electronics, hardware and product design. The pharmaceutical industry, meanwhile, has contributed significant research capabilities and an understanding of complex healthcare needs.

This expanding ecosystem allows innovation centers to move beyond individual activities such as software development or product support. They can increasingly participate in product design, engineering, clinical research, testing and market-model development.

The growth of hospitals and healthcare institutions is particularly important. India now has a large and diverse pool of clinicians, radiologists and other medical experts who can provide insights into unmet needs and product performance. Their experience across different manufacturers and clinical settings can help companies understand what works, what does not and what needs to change.

The availability of patient data and the increasing adoption of preventive healthcare also create opportunities for research and evidence generation. Together, these capabilities enable a more connected approach to innovation -- from identifying a problem and developing an idea to designing, testing and supporting a product.

One of the most significant opportunities is the ability to use India as a testing ground for innovations that can subsequently be scaled globally.

This could involve experimenting with product designs, business models, partnerships or go-to-market approaches. The scale and diversity of the Indian market provide an opportunity to understand how an innovation performs in real-world conditions and how it can be adapted for different needs.

Importantly, this does not necessarily mean designing products that are simply cheaper. Frugal innovation can also mean reducing the physical footprint of a product, integrating more features into a smaller space, improving usability or making technology accessible in settings where infrastructure may be limited.

For healthcare, this can have a powerful impact. The ability to take technology closer to the patient, rather than requiring the patient to travel to specialised facilities, can influence how healthcare is delivered across diverse geographies.

Innovation centers can also act as bridges between different parts of the healthcare ecosystem. Partnerships with hospitals, universities, research institutions and pharmaceutical companies can bring together complementary expertise.

For instance, understanding a disease pathway requires more than treatment alone. Better diagnosis before and after treatment can generate insights that improve patient management and outcomes. Collaboration across diagnostics, imaging, clinical expertise and pharmaceutical research can therefore open new avenues for innovation.

India’s growing research and educational ecosystem adds another layer to this opportunity, providing access to institutions and talent that can contribute to specialised research and technology development.

The evolution of India’s innovation ecosystem changes the role of innovation centers within global healthcare organisations. They are no longer simply extensions created to perform a specific activity efficiently. They can become strategic assets with end-to-end ownership of selected products, technologies or business models.

The opportunity is to build capabilities that span ideation, product development, validation, market experimentation, launch and ongoing product support. In doing so, innovation centers can contribute not only to the growth of the Indian healthcare market but also to the global innovation pipeline.

As India’s healthcare needs continue to evolve—with a growing population, changing demographics and increasing demand for advanced healthcare—the strategic importance of these centres is likely to grow further.

The next phase of India’s healthcare innovation story, therefore, is not simply about doing more work in India. It is about building in India, learning in India and scaling from India to the world.